Dee Sparacio Profile picture
#ovca survivor; research advocate; author; co-moderator #gyncsm chat; COI: https://t.co/AUF1EprNVt Opinions are my own.
Jun 5, 2022 4 tweets 2 min read
I could access the page for #ASCO22 survivorship posters. My favorites:
Prevalence of frailty for middle-aged and older adults starting a new line of systemic cancer treatment: Is age just a number? 1/4
Pergolotti Ab 12054 P300
patient reported Geriatric Assess similar frailty 2/4 Effects of scalp cooling on hair preservation/hair regrowth in breast cancer therapy Brunner P 339 #ASCO22
50% patients w/taxane monotherapy grade 1 alopecia compared to 17% patients w/ anthracycline-taxane
Drop-out: 13% in CAP / 5% in NCAP group
No sig effect in regrowth